Andrea Lopes Pegna
Overview
Explore the profile of Andrea Lopes Pegna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paci E, Puliti D, Carozzi F, Carrozzi L, Falaschi F, Pegna A, et al.
J Med Screen
. 2020 May;
28(1):39-47.
PMID: 32437229
Objectives: Overdiagnosis in low-dose computed tomography randomized screening trials varies from 0 to 67%. The National Lung Screening Trial (extended follow-up) and ITALUNG (Italian Lung Cancer Screening Trial) have reported...
2.
Puliti D, Mascalchi M, Carozzi F, Carrozzi L, Falaschi F, Paci E, et al.
Lung Cancer
. 2019 Oct;
138:72-78.
PMID: 31654837
Objectives: In the ITALUNG lung cancer screening trial after 9.3 years of follow-up we observed an unexpected significant decrease of cardiovascular (CV) mortality in subjects invited for low-dose CT (LDCT)...
3.
Pistelli F, Aquilini F, Falaschi F, Puliti D, Ocello C, Pegna A, et al.
Nicotine Tob Res
. 2019 Sep;
22(9):1484-1491.
PMID: 31504798
Background: Changes in smoking habits and predictors of smoking cessation were examined in the randomized ITALUNG lung cancer screening trial. Methods: In three centers, eligible smokers or ex-smokers (55-69 years,...
4.
Mascalchi M, Comin C, Bertelli E, Sali L, Maddau C, Zuccherelli S, et al.
J Thorac Dis
. 2018 Apr;
10(2):1058-1066.
PMID: 29607181
Occurrence of multiple primary lung cancers (MPLC) in individuals undergoing low-dose computed tomography (LDCT) screening has not been thoroughly addressed. We investigated MPLC in subjects recruited in the ITALUNG randomized...
5.
Carozzi F, Bisanzi S, Carrozzi L, Falaschi F, Pegna A, Mascalchi M, et al.
Int J Cancer
. 2017 Apr;
141(1):94-101.
PMID: 28387927
Asymptomatic high-risk subjects, randomized in the intervention arm of the ITALUNG trial (1,406 screened for lung cancer), were enrolled for the ITALUNG biomarker study (n = 1,356), in which samples...
6.
Paci E, Puliti D, Pegna A, Carrozzi L, Picozzi G, Falaschi F, et al.
Thorax
. 2017 Apr;
72(9):825-831.
PMID: 28377492
Background: ITALUNG is contributing to the European evaluation of low-dose CT (LDCT) screening for lung cancer (LC). Methods: Eligible subjects aged 55-69 years, smokers or ex-smokers (at least 20 pack-years...
7.
Mascalchi M, Pegna A, Carrozzi L, Carozzi F, Falaschi F, Picozzi G, et al.
Thorax
. 2016 May;
71(10):950-1.
PMID: 27217521
No abstract available.
8.
Picozzi G, Falaschi F, Pegna A
Epidemiol Prev
. 2016 Mar;
40(1 Suppl 1):51-5.
PMID: 26951733
In approaching the asbestos-related diseases with CT, both the malignant diseases and the non-malignant disease are to be considered. In the recent publication of the Helsinki Criteria research activities are...
9.
Mascalchi M, Falchini M, Maddau C, Salvianti F, Nistri M, Bertelli E, et al.
J Cancer Res Clin Oncol
. 2015 Jul;
142(1):195-200.
PMID: 26210156
Purpose: Timing and magnitude of blood release of circulating tumour cells (CTC) and circulating tumour microemboli (CTM) from primary solid cancers are uncertain. We investigated prevalence and number of CTC...
10.
Mascalchi M, Attina D, Bertelli E, Falchini M, Vella A, Pegna A, et al.
J Comput Assist Tomogr
. 2014 Oct;
39(1):102-8.
PMID: 25279848
Objective: This study aimed to define computed tomographic morphologic features of lung cancer associated with cystic airspaces, their modifications in serial computed tomographic scans, and 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography...